<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03564483</url>
  </required_header>
  <id_info>
    <org_study_id>17-007532</org_study_id>
    <nct_id>NCT03564483</nct_id>
  </id_info>
  <brief_title>Gynecologic Extramammary Paget's Disease</brief_title>
  <official_title>Prospective Registry of Gynecologic Patients With Extramammary Paget's Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In addition to evaluating treatment outcomes, tissue samples and swabs will be collected as
      part of this study to allow physicians to better understand Extramammary Paget's Disease
      (EMPD). The researchers also want to learn more about the microorganisms (microbiome) that
      live on or near the areas of skin affected by EMPD, in order to better understand this
      condition.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 19, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2027</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2027</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Collect prospective data including outcomes and long-term survival in women with extramammary Paget's disease (EMPD).</measure>
    <time_frame>25 years</time_frame>
    <description>Prospective data including patient demographic information, surgical outcomes, surgical morbidity, recurrence, and long-term survival in extramammary Paget's disease (EMPD) will be collected as part of this registry..</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Extramammary Paget's Disease</condition>
  <condition>Extramammary Paget Disease</condition>
  <condition>Paget Disease, Extramammary</condition>
  <condition>Extramammary Paget's Disease of Vulva (Diagnosis)</condition>
  <condition>Extramammary Paget's Disease of Vagina (Diagnosis)</condition>
  <condition>Extramammary Paget's Disease Vulva Invasive</condition>
  <condition>Extramammary Paget's Disease of Anus (Diagnosis)</condition>
  <condition>Extramammary Paget's Disease of Anal Canal (Diagnosis)</condition>
  <condition>Extramammary Paget's Disease of Skin</condition>
  <arm_group>
    <arm_group_label>Registry Observational Study</arm_group_label>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Tumor tissues will be obtained in order to perform tumor molecular profiling to identify
      targetable somatic mutations in EMPD.

      The vulvar and perianal microbiome of women with extramammary Paget's disease will be
      evaluated.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Women diagnosed with Extramammary Paget's Disease
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Females

          -  Age 18 years or older

          -  Diagnosed with primary or recurrent EMPD of vulva and/or perianal region of the body

          -  Willing and able to provide signed informed consent

        Exclusion Criteria:

          -  Males

          -  Diagnosis of Paget's Disease in body areas other than vulvar or perianal region
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jamie N. Bakkum-Gamez, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Maureen A. Lemens, R.N.</last_name>
    <phone>507-293-1487</phone>
    <email>lemens.maureen@mayo.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Toni Kilts, D.O.</last_name>
    <email>kilts.toni@mayo.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maureen A. Lemens, R.N.</last_name>
      <phone>507-293-1487</phone>
      <email>lemens.maureen@mayo.edu</email>
    </contact>
    <contact_backup>
      <last_name>Toni Kilts, D.O.</last_name>
      <email>kilts.toni@mayo.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Jamie N. Bakkum-Gamez, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>June 11, 2018</study_first_submitted>
  <study_first_submitted_qc>June 11, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 20, 2018</study_first_posted>
  <last_update_submitted>June 15, 2020</last_update_submitted>
  <last_update_submitted_qc>June 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Jamie N. Bakkum-Gamez</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Paget Disease, Extramammary</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

